Crossmark

Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma

Crossref DOI link: https://doi.org/10.1007/s13402-018-0416-2

Published Online: 2018-12-11

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Markman, Renata L.

Webber, Liana P.

Nascimento Filho, Carlos H. V.

Reis, Leonardo A.

Vargas, Pablo A.

Lopes, Marcio A.

Zanella, Virgilio

Martins, Manoela D.

Squarize, Cristiane H.

Castilho, Rogerio M. https://orcid.org/0000-0001-5358-612X
Funding

Funding for this research was provided by:

CAPES (BEX / 88881.132606/2016-01 PDSE)

School of Dentistry, University of Michigan (N/A)

National Cancer Institute (P30 CA046592)
License Information

Text and Data Mining valid from 2018-12-11
More Information

Article History

Accepted: 19 November 2018

First Online: 11 December 2018

Compliance with ethical standards

:

: None declared.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.